Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C in Hard Cataract Phacoemulsification
NCT06781970Recruiting
- Sponsor
- Universitas Indonesia
- Start
- Dec 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ascorbic acid in corneal endothelial cell loss (3 arms), sponsored by Universitas Indonesia. Primary endpoint: Endothelial cell loss at 6 weeks. Started Dec 2024; status: recruiting.
02
Drugs
ascorbic acid
03
Conditions
corneal endothelial cell loss
Beyond the preview
Go deeper on NCT06781970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06781970.